The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 711-718.e2 , March 2010

Naturally processed T cell–activating peptides of the major birch pollen allergen

  • Sonja Mutschlechner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • Christian Doppler Laboratory for Immunomodulation, Department of Pathophysiology, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
  • ,
  • Matthias Egger, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
  • ,
  • Peter Briza, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
  • ,
  • Michael Wallner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
  • ,
  • Peter Lackner, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
  • ,
  • Anette Karle, PhD

      Affiliations

    • F. Hoffmann-La Roche Ltd, Immunosafety, Non-Clinical Safety, Basel, Switzerland
  • ,
  • Anne B. Vogt, PhD

      Affiliations

    • F. Hoffmann-La Roche Ltd, Immunosafety, Non-Clinical Safety, Basel, Switzerland
  • ,
  • Gottfried F. Fischer, MD

      Affiliations

    • Clinical Department for Blood Group Serology, University Clinic for Blood Group Serology and Transfusion Medicine, Vienna, Austria
  • ,
  • Barbara Bohle, PhD

      Affiliations

    • Christian Doppler Laboratory for Immunomodulation, Department of Pathophysiology, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationReprint requests: Barbara Bohle, PhD, Institute of Pathophysiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
    • These authors are cosenior authors of this article.
  • ,
  • Fatima Ferreira, PhD

      Affiliations

    • Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria
    • Corresponding Author InformationFatima Ferreira, PhD, Department of Molecular Biology, University of Salzburg, Hellbrunner Strasse 34, 5020 Salzburg, Austria.
    • These authors are cosenior authors of this article.

Received 10 July 2009 ,Revised 6 October 2009 ,Accepted 29 October 2009.

  • Image Result

    Time kinetics of endolysosomal processing of Bet v 1. After 0.5 to 24 hours of incubation of Bet v 1 with endolysosomal proteases isolated from DCs, generated peptides were sequenced by mass spectrome

    Time kinetics of endolysosomal processing of Bet v 1. After 0.5 to 24 hours of incubation of Bet v 1 with endolysosomal proteases isolated from DCs, generated peptides were sequenced by mass spectrometry. Frequently recognized T-cell epitopes are framed in the amino acid sequence of Bet v 1, shown on top.

  • Image Result
    Optimizing the period for allergen pulsing of DCs. DCs from an individual with birch pollen allergy were incubated with Bet v 1 (5 μg/0.5 × 106 cells) for 6, 11, 24, and 48 hours, respectively, and us

    Optimizing the period for allergen pulsing of DCs. DCs from an individual with birch pollen allergy were incubated with Bet v 1 (5 μg/0.5 × 106 cells) for 6, 11, 24, and 48 hours, respectively, and used to stimulate a Bet v 1–specific T-cell clone. T-cell proliferation (SI) is shown.

  • Image Result
    Naturally processed Bet v 1–derived peptides. Peptides eluted from purified HLA-DR:peptide complexes isolated from DCs of 4 patients with Bet v 1 allergy were sequenced by mass spectrometry. A, Amino

    Naturally processed Bet v 1–derived peptides. Peptides eluted from purified HLA-DR:peptide complexes isolated from DCs of 4 patients with Bet v 1 allergy were sequenced by mass spectrometry. A, Amino acid sequence of Bet v 1. Frequently recognized T-cell epitopes are framed. B, HLA-DR–eluted peptides are shown in black; 12mer peptides inducing proliferative responses in Bet v 1–specific TCLs are shown in gray.

  • Image Result
    T cell–activating properties of naturally processed Bet v 1–derived peptides. Bet v 1–reactive TCCs were stimulated with 2.5 μmol/L of the epitope-containing 12mer peptide (black bars), an 18mer pepti

    T cell–activating properties of naturally processed Bet v 1–derived peptides. Bet v 1–reactive TCCs were stimulated with 2.5 μmol/L of the epitope-containing 12mer peptide (black bars), an 18mer peptide representing the HLA-DR–eluted peptides (white bars), and Bet v 1 (gray bars). TCC218 was stimulated with FKYNYSVIEGGP and FKYNYSVIEGGPIGDTLE. TCC266, TCC334, TCC14VR, and TCC4R were stimulated with TLLRAVESYLLA and GETLLRAVESYLLAHSDA. A, Proliferative responses (SI) are shown. B, Cytokines (pg/mL) were measured by ELISA.

  • Image Result
    Structural determinants of the immunodominant T-cell epitope Bet v 1142-153 (TLLRAVESYLLA). A, Zigzags in the aa sequence of Bet v 1 represent α-helices, arrows indicate β-sheets, and bars represent l

    Structural determinants of the immunodominant T-cell epitope Bet v 1142-153 (TLLRAVESYLLA). A, Zigzags in the aa sequence of Bet v 1 represent α-helices, arrows indicate β-sheets, and bars represent loops. Structure assignments were taken from Protein Data Bank file 1BV1. B, The loop (green) flanking the C-terminal α-helix (golden) containing Bet v 1142-153 is shown in the 3-dimensional structure. C, Surface representation of the loop (green) flanking the C-terminal α-helix (golden) containing Bet v 1142-153. Peptide C-N atoms in the loop region are yellow and blue. The arrow indicates the only solvent-accessible peptide bond. Molecular graphics in B and C were created with UCSF Chimera (PMID: 15264254).

  • Image Result
    Time kinetics of endolysosomal processing of Bet v 1. A, After 0.5 to 24 hours of incubation of Bet v 1 with endolysosomal proteases, 10 μL of the digestion reactions corresponding to 2.5 μg Bet v 1 w

    Time kinetics of endolysosomal processing of Bet v 1. A, After 0.5 to 24 hours of incubation of Bet v 1 with endolysosomal proteases, 10 μL of the digestion reactions corresponding to 2.5 μg Bet v 1 were analyzed by SDS-PAGE and Coomassie staining. M, Marker (kd); B, Bet v 1 in digestion buffer without microsomal fractions. B, Grayscaled and inverted bands corresponding to intact Bet v 1 were quantified as integrated measures of intensity and size using the software Adobe Photoshop CS3. Protein degradation is shown as function of time.

 Supported by P10150 of the Österreichische Nationalbank, the Christian Doppler Laboratory for Allergy Diagnosis and Therapy, and the Christian Doppler Laboratory for Immunomodulation, Austria.

 Disclosure of potential conflict of interest: F. Ferreira has received research support from Biomay AG, the Austrian Science Fund, the Christian Doppler Research Association, and the Austrian National Bank and has provided legal consultation services or expert witness testimony relevant to Indoor Biotechnologies and AllergenOnline Database. B. Bohle has received research support from the Austrian Science Fund and the Christian Doppler Laboratory. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01629-7

doi: 10.1016/j.jaci.2009.10.052

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 711-718.e2 , March 2010